Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma-Reference-Cited by-同舟云学术

Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma

Published:2017-04 Issue:1 Volume:8 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Zhao Xiaohong,Lwin Tint,Silva Ariosto,Shah Bijal,Tao Jiangchuan,Fang Bin,Zhang Liang,Fu Kai,Bi Chengfeng,Li Jiannong,Jiang Huijuan,Meads Mark B.,Jacobson Timothy,Silva Maria,Distler Allison,Darville Lancia,Zhang Ling,Han Ying,Rebatchouk Dmitri,Di Liberto Maurizio,Moscinski Lynn C.,Koomen John M.,Dalton William S.,Shain Kenneth H.,Wang Michael,Sotomayor Eduardo,Tao Jianguo

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms14920.pdf

Reference37 articles.

1. Jares, P., Colomer, D. & Campo, E. Molecular pathogenesis of mantle cell lymphoma. J. Clin. Invest. 122, 3416–3423 (2012).

2. Lwin, T. et al. A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas. J. Clin. Invest. 123, 4612–4626 (2013).

3. Shain, K. H., Dalton, W. S. & Tao, J. The tumor microenvironment shapes hallmarks of mature B-cell malignancies. Oncogene 34, 4673–4682 (2015).

4. Woyach, J. A., Johnson, A. J. & Byrd, J. C. The B-cell receptor signaling pathway as a therapeutic target in CLL. Blood 120, 1175–1184 (2012).

5. Shipp, M. A. BCR signalling and survival pathways in lymphoma. Hematol. Oncol. 33, 140–141 (2015).

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological and clinical determinants shaping heterogeneity in mantle cell lymphoma;BLOOD ADV;2024

2. Biological and clinical determinants shaping heterogeneity in mantle cell lymphoma;Blood Advances;2024-07-11

3. Leveraging altered lipid metabolism in treating B cell malignancies;Progress in Lipid Research;2024-07

4. Targeting lipid metabolism overcomes BTK inhibitor resistance in diffuse large B-cell lymphoma;Medicine in Novel Technology and Devices;2024-06

5. Bruton Tyrosine Kinase Degraders in B-Cell Malignancies;Molecular Cancer Therapeutics;2024-05-02